http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0640923-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
filingDate 1993-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf4d8fe8ccf21edc1458a6d5a30f602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59929a7701ed44bfdcf3295f5029bdb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6c5d11ab3fb464a99cfa382c4f7d148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aa4d1999037129977863578010cfe23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de87abd1f3457d9f6628f55050ceba3
publicationDate 1994-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0640923-A
titleOfInvention Cytarabine ocfosfate hard capsule
abstract (57) [Summary] [Structure] (1) Cytarabine ocfosfate hard capsules containing (1) cytarabine ocfosfate, (2) a polymer compound acting as a disintegrant and (3) an alkali are provided. To do. [Effect] The hard capsule according to the present invention is excellent in both disintegrating property and COP stability and is useful as an oral antitumor agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006109635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293274-B2
priorityDate 1992-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426121977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451849165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331

Total number of triples: 41.